Immunosuppressive cells in tumor immune escape and metastasis
- PMID: 26689709
- DOI: 10.1007/s00109-015-1376-x
Immunosuppressive cells in tumor immune escape and metastasis
Abstract
Tumor immune escape and the initiation of metastasis are critical steps in malignant progression of tumors and have been implicated in the failure of some clinical cancer immunotherapy. Tumors develop numerous strategies to escape immune surveillance or metastasize: Tumors not only modulate the recruitment and expansion of immunosuppressive cell populations to develop the tumor microenvironment or pre-metastatic niche but also switch the phenotype and function of normal immune cells from a potentially tumor-reactive state to a tumor-promoting state. Immunosuppressive cells facilitate tumor immune escape by inhibiting antitumor immune responses and furthermore promote tumor metastasis by inducing immunosuppression, promoting tumor cell invasion and intravasation, establishing a pre-metastatic niche, facilitating epithelial-mesenchymal transition, and inducing angiogenesis at primary tumor or metastatic sites. Numerous translational studies indicate that it is possible to inhibit tumor immune escape and prevent tumor metastasis by blocking immunosuppressive cells and eliminating immunosuppressive mechanisms that are induced by either immunosuppressive cells or tumor cells. Furthermore, many clinical trials targeting immunosuppressive cells have also achieved good outcome. In this review, we focus on the underlying mechanisms of immunosuppressive cells in promoting tumor immune escape and metastasis, discuss our current understanding of the interactions between immunosuppressive cells and tumor cells in the tumor microenvironment, and suggest future research directions as well as potential clinical strategies in cancer immunotherapy.
Keywords: Cancer immunotherapy; Immune escape; Immunosuppressive cell; Metastasis; Tumor microenvironment.
Similar articles
-
Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.J Immunol. 2016 Aug 1;197(3):691-8. doi: 10.4049/jimmunol.1600458. J Immunol. 2016. PMID: 27431984 Free PMC article. Review.
-
Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.Int Rev Immunol. 2019;38(6):267-283. doi: 10.1080/08830185.2019.1669593. Epub 2019 Oct 3. Int Rev Immunol. 2019. PMID: 31578892 Review.
-
The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy.Front Immunol. 2021 Apr 13;12:654877. doi: 10.3389/fimmu.2021.654877. eCollection 2021. Front Immunol. 2021. PMID: 33927723 Free PMC article. Review.
-
The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.Crit Rev Immunol. 2020;40(2):157-166. doi: 10.1615/CritRevImmunol.2020033492. Crit Rev Immunol. 2020. PMID: 32749093
-
The multifaceted role of mesenchymal stem cells in cancer.Semin Cancer Biol. 2020 Feb;60:225-237. doi: 10.1016/j.semcancer.2019.06.003. Epub 2019 Jun 15. Semin Cancer Biol. 2020. PMID: 31212021 Review.
Cited by
-
Ferroptosis: A potential opportunity for intervention of pre-metastatic niche.Front Oncol. 2022 Sep 9;12:980620. doi: 10.3389/fonc.2022.980620. eCollection 2022. Front Oncol. 2022. PMID: 36158661 Free PMC article. Review.
-
Tumor-associated neutrophils in pancreatic cancer progression and metastasis.Am J Cancer Res. 2023 Dec 15;13(12):6176-6189. eCollection 2023. Am J Cancer Res. 2023. PMID: 38187037 Free PMC article. Review.
-
Construction of an Immune Escape-Related Signature in Clear Cell Renal Cell Carcinoma and Identification of the Relationship between IFNAR1 and Immune Infiltration by Multiple Immunohistochemistry.Cancers (Basel). 2022 Dec 28;15(1):169. doi: 10.3390/cancers15010169. Cancers (Basel). 2022. PMID: 36612165 Free PMC article.
-
Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells.Front Oncol. 2019 Feb 21;9:82. doi: 10.3389/fonc.2019.00082. eCollection 2019. Front Oncol. 2019. PMID: 30847298 Free PMC article. Review.
-
Preclinical Solid Tumor Models to Study Novel Therapeutics in Brain Metastases.Curr Protoc. 2021 Nov;1(11):e284. doi: 10.1002/cpz1.284. Curr Protoc. 2021. PMID: 34762346 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical